Table Of Contents
1 Introduction 10
1.1 Objectives Of The Study 10
1.2 Market Definition 10
1.3 Overview Of U.S.,U.K.,Canada Skin Graft Market 10
1.4 Currency And Pricing 11
1.5 Limitation 11
1.6 Markets Covered 11
2 Market Segmentation 13
2.1 Markets Covered 13
2.2 Geographic Scope 14
2.3 Years Considered For The Study 14
2.4 Currency And Pricing 14
2.5 Research Methodology 15
2.6 Primary Interviews With Key Opinion Leaders 19
2.7 Secondary Sources 20
2.8 Assumptions 20
3 Market Overview 21
3.1 Drivers 23
3.1.1 Increasing Number Of Burns Injuries, Pressure Ulcers And Skin Infections 23
3.1.2 Technological Advancements And Developments In Skin Grafting Techniques 24
3.1.3 Favorable Reimbursement Policies For Skin Grafting Procedure 25
3.2 Restraints 26
3.2.1 Side Effects Related To The Skin Graft Procedure 26
3.3 Opportunities 27
3.3.1 Increasing Medical Tourisms 27
3.4 Challenges 28
3.4.1 Competition Among Major Players 28
4 Executive Summary 29
5 Premium Insights 33
5.1 Increasing Number Of Burns Injuries, Pressure Ulcers, Skin Infections, And Developments In Skin Grafting Techniques Are Expected To Drive The Market For U.S., U.K., Canada Skin Graft In The Forecast Period 2018 To 2025 33
6 U.S.,U.K.,Canada Skin Graft Market, By Type 37
6.1 Overview 38
6.2 Autologous 41
6.3 Isogeneic 42
6.4 Allogeneic 42
6.5 Xenogeneic 43
6.6 Prosthetic 43
7 U.S., U.K., Canada Skin Graft Market, By Graft Thickness 44
7.1 Overview 45
7.2 Split-Thickness 48
7.3 Full-Thickness 49
7.4 Composite Graft 49
8 U.S., U.K., Canada Skin Graft Market, By Application 50
8.1 Overview 51
8.2 Burns 54
8.3 Extensive Wound 55
8.4 Extensive Skin Loss Due To Infection 55
8.5 Skin Cancer 56
9 U.S., U.K., Canada Skin Graft Market, By Equipment Type 57
9.1 Overview 58
9.2 Dermatome 62
9.2.1 Knife Dermatomes 64
9.2.1.1 Blair/Brown Knife 66
9.2.1.2 Watson Knife 66
9.2.1.3 Cobbett Knife 67
9.2.2 Drum Dermatomes 67
9.2.2.1 Padgett Dermatomes 69
9.2.2.2 Reese Dermatomes 69
9.2.3 Electrical Dermatomes 70
9.2.4 Air-Powdered Dermatomes 70
9.3 General Surgical Instruments 71
9.4 Consumables 71
9.5 Others 72
10 U.S., U.K., Canada Skin Graft Market, By End User 73
10.1 Overview 74
10.2 Hospitals 77
10.3 Dermatology Clinics 77
10.4 Ambulatory Surgical Centers 77
11 U.S.,U.K.,Canada Skin Graft Market, Company Landscape 78
11.1 Company Share Analysis; North America 78
11.2 Company Share Analysis; Europe 79
12 Company Profiles 80
12.1 Integra Lifesciences Corporation 80
12.1.1 Company Overview 80
12.1.2 Integra Lifesciences Corporation; Revenue Analysis 80
12.1.3 Product Portfolio 81
12.1.4 Recent Developments 82
12.2 Organogenesis Inc. 83
12.2.1 Company Overview 83
12.2.2 Organogenesis Inc.; Company Snapshot 83
12.2.3 Product Portfolio 83
12.2.4 Recent Developments 84
12.3 Zimmer Biomet 85
12.3.1 Company Overview 85
12.3.2 Zimmer Biomet; Revenue Analysis 85
12.3.3 Product Portfolio 86
12.3.4 Recent Developments 86
12.4 B. Braun Melsungen Ag 87
12.4.1 Company Overview 87
12.4.2 B. Braun Melsungen Ag; Revenue Analysis 87
12.4.3 Product Portfolio 88
12.4.4 Recent Developments 88
12.5 Avita Medical 89
12.5.1 Company Overview 89
12.5.2 Avita Medical; Revenue Analysis 89
12.5.3 Product Portfolio 90
12.5.4 Recent Developments 90
12.6 De Soutter Medical 91
12.6.1 Company Overview 91
12.6.2 De Soutter Medical; Company Snapshot 91
12.6.3 Product Portfolio 91
12.6.4 Recent Developments 91
12.7 Exsurco Medical, Inc. 92
12.7.1 Company Overview 92
12.7.2 Exsurco Medical, Inc; Company Snapshot 92
12.7.3 Product Portfolio 92
12.7.4 Recent Developments 92
12.8 Mallinckrodt 93
12.8.1 Company Overview 93
12.8.2 Mallinckrodt; Revenue Analysis 93
12.8.3 Product Pipeline 94
12.8.4 Recent Developments 94
12.9 Nouvag 95
12.9.1 Company Overview 95
12.9.2 Nouvag; Company Snapshot 95
12.9.3 Product Portfolio 95
12.9.4 Recent Developments 95
12.10 Surtex Instruments Limited 96
12.10.1 Company Overview 96
12.10.2 Surtex Instruments Limited; Company Snapshot 96
12.10.3 Product Portfolio 96
12.10.4 Recent Developments 96
12.11 Tissue Regenix 97
12.11.1 Company Overview 97
12.11.2 Tissue Regenix; Revenue Analysis 97
12.11.3 Product Portfolio 98
12.11.4 Recent Developments 98
13 Related Reports 99
?